Metformin and adipose-derived stem cell combination therapy alleviates radiation-induced skin fibrosis in mice

Hamid Malekzadeh,Yusuf Surucu,Somaiah Chinnapaka,Katherine S. Yang,José A. Arellano,Yasamin Samadi,Michael W. Epperly,Joel S. Greenberger,J. Peter Rubin,Asim Ejaz

DOI: https://doi.org/10.1186/s13287-023-03627-7

2024-01-10

Stem Cell Research & Therapy

Abstract:Radiation therapy often leads to late radiation-induced skin fibrosis (RISF), causing movement impairment and discomfort. We conducted a comprehensive study to assess the effectiveness of metformin and adipose-derived stem cells (ASCs), whether autologous or allogeneic, individually or in combination therapy, in mitigating RISF.

cell biology,medicine, research & experimental,cell & tissue engineering

What problem does this paper attempt to address?

The paper attempts to address the issue of Radiation-Induced Skin Fibrosis (RISF). Specifically, the study aims to evaluate whether Metformin and Adipose-Derived Stem Cells (ASCs), used alone or in combination, can effectively prevent and treat skin fibrosis caused by radiation. The study explores the effects of these treatments in preventing and treating RISF using a mouse model.

### Research Background
Radiation therapy is an important method in modern cancer treatment, but it often leads to late-stage radiation-induced skin fibrosis (RISF), which can cause mobility issues and discomfort. RISF is a complex pathological process involving the dysregulation of various cellular and non-cellular factors, leading to excessive extracellular matrix (ECM) deposition. Currently, there are no effective treatments to manage RISF.

### Research Objectives
1. **Evaluate Preventive Treatment**: Study the effects of Metformin and ASCs in preventing RISF.
2. **Evaluate Therapeutic Treatment**: Study the effects of Metformin and ASCs in treating existing RISF.
3. **Compare Different Treatment Methods**: Compare the effects of autologous ASCs, allogeneic ASCs, Metformin alone, and their combination.

### Main Findings
- **Preventive Treatment**:
- Metformin and ASCs (whether autologous or allogeneic) can effectively prevent late-stage fibrosis, with Metformin showing significant effects.
- Combined treatment did not show additional benefits in preventive applications.
- Autologous ASCs used alone or in combination with Metformin were most effective in preventing late-stage RISF.
- **Therapeutic Treatment**:
- Preventive intervention is more effective than late-stage treatment in reducing radiation-induced skin damage.
- Autologous ASCs used alone or in combination with Metformin were most effective in treating late-stage RISF.
- **Mechanism Study**:
- Metformin and ASCs can downregulate the expression of inflammation and fibrosis genes, thereby reducing fibrosis occurrence.

### Conclusion
The study suggests Metformin as a potential measure for preventing RISF, and the combination of Metformin and ASCs shows promise in treating late-stage RISF. These findings have significant clinical implications for improving the quality of life of patients affected by radiation-induced skin fibrosis.